Despite high prevalence and increased severity and burden of overactive bladder (OAB) and fecal incontinence (FI) in the elderly, sacral neuromodulation (SNM) is often overlooked as a potential treatment option for this demographic. In this study, we report the outcomes of SNM in patients aged 75 years or older at the time of surgery.
We conducted a retrospective cohort study of patients who underwent SNM implantation between 2013 and 2022 performed by a single, high-volume urologist at a tertiary center. Success, complication, and adjunct therapy rates were analyzed by Fisher's or Wilcox rank-sum test as appropriate. We compared outcomes between patients aged 75-79 years and octogenarians.
Of 632 patients, 50 were ≥75 years. Patients had a mean age of 78.4±2.6 years and were predominantly female (84%). The indications for SNM were 66% OAB, 16% FI, 16% non-obstructive urinary retention, and 4% pelvic pain. Within the first year, 94% of patients reported satisfaction and improvement in symptoms, while 76% continued to experience improvement beyond one year. SNM insertion led to reduced oral medication use from 68% to 24% (p<0.0001). The complication rate was 16% and mostly included device pain. No significant difference was observed in treatment success, complication, or adjunct therapy rate between age groups.
SNM is a safe and effective option in well-selected patients over the age of 75 years. Treatment success rate is comparable to younger cohorts. Advanced age should not preclude third-line therapy options in this population.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2024 Mar [Epub]
Roseanne Ferreira, Samuel Otis-Chapados, Emad Alwashmi, Naeem Bhojani, Kevin C Zorn, Bilal Chughtai, Dean S Elterman
Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada., Division of Urology, University Health Network, Toronto, ON, Canada., University of Montreal Hospital Center, Université de Montréal, Montreal, QC, Canada., New York Presbyterian Hospital-Weill Cornell, New York, NY, United States.